Insiders REGENXBIO Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 20:03:02 10/05/2024 BST			5-day change	1st Jan Change
15.22 ^USD	-2.93%		-9.51%	-15.15%

05-09	UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating	MT
05-08	Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024

Regenxbio Insider Sold Shares Worth $365,220, According to a Recent SEC Filing	03-08	MT
Regenxbio Insider Sold Shares Worth $299,789, According to a Recent SEC Filing	01-04	MT
Regenxbio Insider Sold Shares Worth $885,825, According to a Recent SEC Filing	12-21	MT
Regenxbio Promotes Curran Simpson to Chief Operating Officer	10/01/23	MT
REGENXBIO Inc. Announces Executive Promotions	09/01/23	CI
Insider Sell: Regenxbio	15/07/22	MT
Regenxbio Inc. Appoints Jennifer Zachary to its Board of Directors	07/06/22	CI
Daniel J. Abdun-Nabi Notifies REGENXBIO Inc. Will Not Stand for Re-Election	18/03/22	CI
Insider Sell: Regenxbio	27/12/21	MT
Insider Sell: Regenxbio	15/09/21	MT
REGENXBIO Inc. Announces Executive Changes	07/09/21	CI
Insider Trends: REGENXBIO Sees 90 Days of Insider Buying Trend Scaling Back with Share Sale	14/01/21	MT
Insider Trends: REGENXBIO Sees 90 Days of Insider Buying Trend Reducing with Share Sale	11/01/21	MT
Insider Trends: Insider Prolongs 90-Day Selling Trend at REGENXBIO	28/12/20	MT
Insider Trends: REGENXBIO Insider Continues 90-Day Selling Trend	14/12/20	MT
REGENXBIO Appoints Olivier Danos to its Board of Directors	04/11/20	CI
REGENXBIO Inc. Announces Board Changes	02/07/20	CI
REGENXBIO Inc. Elects Alexandra Glucksmann as Member of Its Compensation Committee	03/06/19	CI
REGENXBIO Appoints Steve Pakola as Chief Medical Officer	17/04/19	CI
REGENXBIO Inc. Announces Resignation of Stephen Yoo as Chief Medical Officer with Effect from December 31, 2018	07/11/18	CI

No results for this search